Related Experiment Video
Updated: Aug 7, 2026

Development of a Virtual Reality Assessment of Everyday Living Skills
Published on: April 23, 2014
Epidemiology, clinical consequences, and psychosocial treatment of nonadherence in schizophrenia
1Klinik und Poliklinik für Psychiatrie und Psychotherapie, Klinikum rechts der Isarder, Technischen Universität München, Ismaningerstrasse 22, 81675 Munich, Germany. stefan.leucht@lrz.tu-muenchen.de
Abstract:
Partial adherence and nonadherence to medication continue to be problems in the treatment of patients with schizophrenia. Nonadherence to medication has a negative impact on the course of illness for these patients as is shown by data on relapse, rehospitalization, time to remission, and attempted suicide. Several factors that contribute to poor adherence have been identified and need to be taken into account when attempting to address the problem of nonadherence. These risk factors relate to the patient, his or her illness and social situation, and the physician. Among the measures that have the potential to improve adherence to medication are psychosocial interventions, psychoeducation in the form of professional, peer-to-peer or family-to-family interventions, and shared decision making.
Related Concept Videos
Drug Therapy
Antianxiety Medications
Psychological and Sociocultural Causes of Schizophrenia
Psychosis: Goals of Pharmacotherapy
Psychosis and Antipsychotic Drugs: Overview
Schizophrenia
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within the...